BioSpace News Archive

Yield10 Bioscience, Inc., an agricultural bioscience company, announced that the Company has secured all of the regulatory permits required to conduct field tests for multiple traits at sites in the United States and Canada contracted for the 2020 growing season.

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced that Chief Executive Officer Peter Miller will present a company overview and business update at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2020, at 10:20 a.m. ET.

21% Year-Over-Year Revenue Growth; 51% Sequential Increase in Authorization Backlog

Initiated Third and Final Cohort of the Multiple Ascending Dose Study of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease

Yield10 Bioscience, Inc., an agricultural bioscience company, reported financial results for the three months ended March 31, 2020.

Applied DNA Sciences Inc. a leader in Polymerase Chain Reaction -based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, announced consolidated financial results for the fiscal second quarter and the six months ended March 31, 2020.

Atara Biotherapeutics, Inc., a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including solid tumors, hematologic cancers and autoimmune disease, named cell therapy and oncology expert Jakob Dupont, M.D. as Executive Vice President, Global Head of Research and Development.

Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, announced today that it will report its unaudited financial results for the first quarter 2020 before the U.S. market opens on Thursday, May 28, 2020.

Ferring Pharmaceuticals announced today a publication in Fertility and Sterility highlighting MEGASET-HR, a 620 patient, non-inferiority trial comparing Menopur (menotropins for injection) to rFSH, which suggests an opportunity to individualize treatment for predicted high responders.

Companies selling personal protective equipment like face masks and gloves seem to be having a hard time getting their products to their target audience, no thanks to the practices of online platforms such as search engines, online stores, and social media networking sites.